Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Oberste

Showing results (71-80 of 227) with videos related to

Pageof 23
Sort By:
Journal of Virological Methods|August 13, 2021
Use of guanidine thiocyanate-based nucleic acid extraction buffers to inactivate poliovirus in potentially infectious materialsMichelle J Honeywood, Stacey Jeffries-Miles, Kimberly Wong, et al.
BMC Infectious Diseases|August 25, 2009
Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in KenyaNino Khetsuriani, Rita Helfand, Mark Pallansch, et al.
The Journal of Infectious Diseases|October 31, 2008
Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005Ashley L Fowlkes, Somayeh Honarmand, Carol Glaser, et al.
The Pediatric Infectious Disease Journal|September 18, 2014
First use of investigational antiviral drug pocapavir (v-073) for treating neonatal enteroviral sepsisSanet Torres-Torres, Angela L Myers, J Michael Klatte, et al.
Genome Announcements|February 20, 2016
Characterization of a Salivirus (Picornaviridae) from a Diarrheal Child in GuatemalaTerry Fei Fan Ng, Laura Magaña, Anna Montmayeur, et al.
Vaccine|January 24, 2018
Assessment of poliovirus antibody seroprevalence in polio high risk areas of West AfricaOumar Guindo, Ondrej Mach, Seydou Doumbia, et al.
Viruses|August 10, 2021
Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in PanamaMagda Rojas-Bonilla, Angela Coulliette-Salmond, Hanen Belgasmi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2010
Infant deaths associated with human parechovirus infection in WisconsinGerald Sedmak, W Allan Nix, Jeffrey Jentzen, et al.
Journal of Medical Virology|November 20, 2013
Infection of human islets of Langerhans with two strains of Coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathwayMahesh Anagandula, Sarah J Richardson, M Steven Oberste, et al.
Vaccine|November 19, 2017
Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedulesAnanda S Bandyopadhyay, Edwin J Asturias, Miguel O'Ryan, et al.
Pageof 23

Showing results (71-80 of 227) with videos related to

Sort By:
Pageof 23
Journal of Virological Methods|August 13, 2021
Use of guanidine thiocyanate-based nucleic acid extraction buffers to inactivate poliovirus in potentially infectious materialsMichelle J Honeywood, Stacey Jeffries-Miles, Kimberly Wong, et al.
BMC Infectious Diseases|August 25, 2009
Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in KenyaNino Khetsuriani, Rita Helfand, Mark Pallansch, et al.
The Journal of Infectious Diseases|October 31, 2008
Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005Ashley L Fowlkes, Somayeh Honarmand, Carol Glaser, et al.
The Pediatric Infectious Disease Journal|September 18, 2014
First use of investigational antiviral drug pocapavir (v-073) for treating neonatal enteroviral sepsisSanet Torres-Torres, Angela L Myers, J Michael Klatte, et al.
Genome Announcements|February 20, 2016
Characterization of a Salivirus (Picornaviridae) from a Diarrheal Child in GuatemalaTerry Fei Fan Ng, Laura Magaña, Anna Montmayeur, et al.
Vaccine|January 24, 2018
Assessment of poliovirus antibody seroprevalence in polio high risk areas of West AfricaOumar Guindo, Ondrej Mach, Seydou Doumbia, et al.
Viruses|August 10, 2021
Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in PanamaMagda Rojas-Bonilla, Angela Coulliette-Salmond, Hanen Belgasmi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2010
Infant deaths associated with human parechovirus infection in WisconsinGerald Sedmak, W Allan Nix, Jeffrey Jentzen, et al.
Journal of Medical Virology|November 20, 2013
Infection of human islets of Langerhans with two strains of Coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathwayMahesh Anagandula, Sarah J Richardson, M Steven Oberste, et al.
Vaccine|November 19, 2017
Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedulesAnanda S Bandyopadhyay, Edwin J Asturias, Miguel O'Ryan, et al.
Pageof 23